0 Yorumlar
0 hisse senetleri
545 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Generic Oncology Drugs Market to See Consistent Growth Through 2036 Amid Rising Focus on Expanding Cancer Care AccessNEWARK, Del., July 17, 2026 — The Generic Oncology Drugs Market is expected to witness steady growth as healthcare systems worldwide increasingly prioritize affordable cancer treatment and broader patient access to life-saving therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 24.4 billion in 2026 to USD 31.5 billion by 2036, registering a 2.6%...0 Yorumlar 0 hisse senetleri 310 Views 0 önizleme
-
Generic Oncology Drugs Market to See Consistent Growth Through 2036 Amid Rising Focus on Expanding Cancer Care AccessNEWARK, Del., July 17, 2026 — The Generic Oncology Drugs Market is expected to witness steady growth as healthcare systems worldwide increasingly prioritize affordable cancer treatment and broader patient access to life-saving therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 24.4 billion in 2026 to USD 31.5 billion by 2036, registering a 2.6%...0 Yorumlar 0 hisse senetleri 396 Views 0 önizleme
-
Global Cancer Drugs Market Set for Exponential Growth, Targeting USD 1.81 Billion by 2032 as Immunotherapies Reshape Oncology LandscapeMarket Projected to Accelerate at 4.71% CAGR Driven by Precision Medicine Adoption and the Rise of Novel Cell and Gene Therapies The global Cancer Drugs Market, highlighting a profound shift toward curative and highly targeted therapeutic modalities. The market, valued at a substantial USD 1.19 Billion in 2023, is projected to reach USD 1.81 Billion by 2032, recording a robust Compound Annual...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
High Potency API Market: Increasing Investments in Oncology Drugs and Specialized ManufacturingAccording to a new report published by Introspective Market Research, titled, High Potency Active Pharmaceutical Ingredients Market by Type, Synthesis, and Application, The Global High Potency Active Pharmaceutical Ingredients Market Size Was Valued at USD 26.42 Billion in 2023 and is Projected to Reach USD 66.71 Billion by 2032, Growing at a CAGR of 10.84%. 2. Introduction / Market...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Oncology Drugs Market Growth: Trends, Opportunities, and Future OutlookThe global Oncology Drugs Market is poised for remarkable growth during the forecast period from 2025 to 2033, driven by the rising global cancer burden, continuous innovation in targeted therapies, increasing investments in oncology research, and expanding access to advanced cancer treatments. Valued at approximately USD 253.6 billion in 2025, the market is projected to...0 Yorumlar 0 hisse senetleri 134 Views 0 önizleme
-
Oncology Drugs Market Outlook 2026–2034 Innovations Driving the Future of Cancer TreatmentThe Oncology Drugs Market is experiencing remarkable growth, driven by the increasing global burden of cancer, continuous advancements in targeted therapies, and expanding adoption of personalized medicine. As healthcare systems worldwide focus on improving cancer survival rates and treatment outcomes, oncology drugs are becoming a cornerstone of modern healthcare and pharmaceutical...0 Yorumlar 0 hisse senetleri 397 Views 0 önizleme
-
Oncology Drugs Market Trends, Growth, and Breakthrough TherapiesOncology Drugs Market Report: Rising Demand for Precision Medicine and Immunotherapies The oncology drugs market is anticipated to experience substantial growth from 2025 to 2033, increase in the adoption of automation technologies in the food and beverage industry being a key factor propelling this growth. With an estimated valuation of approximately USD 253.6 billion in...0 Yorumlar 0 hisse senetleri 713 Views 0 önizleme
-
Oncology Drugs Market Trends, Growth, and Breakthrough TherapiesOncology Drugs Market Report: Rising Demand for Precision Medicine and Immunotherapies The oncology drugs market is anticipated to experience substantial growth from 2025 to 2033, increase in the adoption of automation technologies in the food and beverage industry being a key factor propelling this growth. With an estimated valuation of approximately USD 253.6 billion in...0 Yorumlar 0 hisse senetleri 763 Views 0 önizleme
-
Oral Mucositis Drugs Market Advances with Novel Supportive Care Therapies and Growing Oncology Treatment DemandAccording to the latest report published by Data Bridge Market Research, the Oral Mucositis Drugs Market Data Bridge Market Research analyses that the global oral mucositis drugs market which was USD 530.00 million in 2023, would rocket up to USD 896.62 million by 2030, and is expected to undergo a CAGR of 7.80% during the forecast period. This Oral Mucositis Drugs Market research...0 Yorumlar 0 hisse senetleri 526 Views 0 önizleme
-
Revealed: The Future of Oncology Drugs Market is Brighter Than EverThe oncology drugs landscape is set for transformative changes, with the market experiencing a remarkable trajectory of growth. By 2035, the oncology drugs market is set to reach a staggering USD 763.21 billion, reflecting a compound annual growth rate (CAGR) of 14.2%. This expansion is not simply a byproduct of increased cancer incidence; it is also driven by groundbreaking advancements in...0 Yorumlar 0 hisse senetleri 230 Views 0 önizleme
-
Role of Government Policies in Strengthening the United States Generic Oncology Drugs MarketThe United States represents a major segment of the Generic Oncology Drugs Market, driven by the high burden of cancer and increasing demand for cost-effective treatment options. Rising healthcare expenditures and the need to improve affordability in cancer care are encouraging wider adoption of generic oncology drugs across hospitals, oncology clinics, and specialty centers. The presence of...0 Yorumlar 0 hisse senetleri 321 Views 0 önizleme
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Yorumlar 0 hisse senetleri 9K Views 0 önizleme
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme
-
Anti-Radiation Drugs Market Size, Share, and Strategic OutlookAdvancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Yorumlar 0 hisse senetleri 7K Views 0 önizleme
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme1
-
Estramustine Phosphate Sodium Market Dynamics and Opportunities 2031Estramustine Phosphate Sodium is an oncology drug primarily indicated for the treatment of metastatic or advanced prostate cancer. It integrates estrogenic components with cytotoxic activity to inhibit cancer cell proliferation. By targeting tumor cell division pathways, it supports disease control in patients requiring specialized therapeutic interventions. Market Overview The Estramustine...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Geographic Share Dynamics and Strategic Growth in Adult Malignant Glioma Therapeutics Market: Analysis and Forecast to 2031The global healthcare industry is witnessing significant transformation in oncology, particularly in the treatment of aggressive brain tumors such as malignant gliomas in adults. Increasing prevalence of glioblastoma, coupled with advancements in targeted therapies, immunotherapy, and precision medicine, is reshaping treatment approaches and improving patient outcomes. Rising investments in...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme1
Arama Sonuçları